New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
09:11 EDTCVRR, OMI, AERI, GIS, PXD, MDCI, NSPH, MON, IMS, SQBG, GLNG, BMY, BKSOn The Fly: Pre-market Movers
HIGHER: Barnes & Noble (BKS), up 7.7% after board authorizes management to separate Retail, Nook Media units... Monsanto (MON), up 5% after reporting better than expected Q3 results, raising its full year EPS outlook to the upper end of its previous guidance range and announcing a new $10B share repurchase authorization... IMS Health (IMS), up 7.7% after acquiring certain Cegedim businesses for $520M... Nanosphere (NSPH), up 16.2% after receiving 510(k) clearance for bacterial portion of Verigene EP test... Aerie Pharmaceuticals (AERI), up 37% after its trial of Roclatan achieved its primary efficacy endpoint... Medical Action (MDCI), up 94% after Owens & Minor (OMI) acquires the company for $13.80 per share in cash... Sequential Brands (SQBG), up 15% after acquiring Galaxy Brand for $100M cash, 13.75M shares... Pioneer Natural (PXD), up 2.3% after media reports that the company got U.S. permission to ship a type of light oil known as condensate... Bristol-Myers Squibb (BMY), up 2% after a Phase 3 study of nivolumab was halted early due to superior data. LOWER: General Mills (GIS), down 3.7% after Q4 earnings fall below analyst's consensus... Lindsay Corp. (LNN), down 5% after earnings miss, saying Iraq contract now more difficult to complete... Golar LNG (GLNG), down 2% after 11M share offering priced at $54 per share... CVR Refining (CVRR), down 7% after 6M share secondary offering of common units price at $26.07.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
November 18, 2015
09:55 EDTMONMonsanto plans to continue to target 1.5x net debt to ongoing EBITDA ratio
Subscribe for More Information
09:54 EDTMONMonsanto expects core pipeline to deliver up to $25B of peak net sales
The company said innovation is expected to underpin 80% of the gross profit growth to 2019. It expects the company is tracking toward the 3rd straight year of greater than 20 pipeline advancements. Comments taken from slides for Monsanto Biennial Investor Event.
09:06 EDTGISHain Celestial weakness looks overdone, says Bernstein
Bernstein notes that Hain Celestial (HAIN) is now trading at a lower valuation than a number of "ostensibly more challenged food companies like" Kellogg (K) and General Mills (GIS). The firm expects the company to benefit over the longer term from current food trends. It trimmed its price target on the name to $50 from $60 and keeps an Outperform rating.
08:11 EDTBMYIMS Health forecasts global drug spending to increase 30% by 2020 to $1.4T
Subscribe for More Information
06:03 EDTMONBayer says not looking to sell crop chemicals business, Reuters reports
Bayer (BAYRY) says its Bayer CropScience unit is an "integral part" of the company and that the division is not for sale, Reuters reports. Bayer's comments come after Monsanto (MON) executives said that it is in internal discussions about tie-ups in the industry. Reference Link
06:01 EDTMONMonsanto studying possibility for consolidation in agrochem sector, Reuters says
Subscribe for More Information
November 17, 2015
16:26 EDTMONOn The Fly: Top stock stories for Tuesday
Stocks on Wall Street see-sawed throughout the day and eventually finished the day mixed, with solid earnings reports from both Wal-Mart (WMT) and Home Depot (HD) helping the Dow notch a small gain while the S&P recorded a small loss. The averages looked to be set to extend yesterday's advance, but weakened during the afternoon following news of a stadium evacuation in Europe that unsettled investors and put a halt to the rally. The market struggled into the close but avoided a big selloff as headlines crossed that police in Germany found no explosives at the site of the game cancellation in Hanover. ECONOMIC EVENTS: In the U.S., the consumer price index rose 0.2% in October, as expected. When food and energy prices are stripped out, the "core" CPI also rose 0.2%, also matching the consensus forecast. Industrial production slid 0.2% in October, versus expectations for it to have risen 0.1%. Capacity utilization came in as expected at 77.5%. NAHB's home builder sentiment index fell 3 points to 62 in November, versus expectations for a reading of 64. COMPANY NEWS: Shares of Wal-Mart advanced 3.5% to $59.92 after the world's largest retailer reported better than expected quarterly earnings and gave a fiscal year profit outlook that was higher than expected at the midpoint of the company's range. Another retail giant and fellow Dow member, Home Depot, gained 4.4% to $126.18 while TJX (TJX), owner of the TJ Maxx and HomeGoods brands, rose nearly 4% to $68.18 after their own better than expected quarterly reports. Missing out on the retail rally, however, was Dick's Sporting Good (DKS), which tumbled 9.4% to $36.96 after giving guidance for the holiday quarter and fiscal 2015 that missed consensus estimates. MAJOR MOVERS: Among the notable gainers was Airgas (ARG), which jumped $31.17, or 29.39%, to $137.35 after agreeing to be acquired by Air Liquide for $143 per share. Also higher was Syngenta (SYT), which advanced $6.69, or 9.24%, to $79.06 after Monsanto (MON) Chief Operating Officer Brett Begemann told reporters the company is weighing another attempt at acquiring the Swiss firm. Among the noteworthy losers were GNC (GNC), Vitamin Shoppe (VSI), and Natural Health (NHTC), which dropped a respective 6.4%, 5%, and 15.4% after the Department of Justice said in a media advisory that it would announce actions related to dietary supplements sales and unlawful ads. Shares in the publicly traded companies came off their lows, but did not fully recover heading into the close, after the agency announced that its criminal case was charging USPlabs and that its five civil cases were against a number of smaller businesses. Also lower was SunEdison (SUNE), which fell $1.54, or 33.74%, to $3.02, with Oppenheimer attributing the selloff to "unsubstantiated rumors" regarding its liquidity and Deutsche Bank saying language in Vivint Solar's (VSLR) quarterly filing around SunEdison debt financing could concern some investors who are focused on the balance sheet. Additionally, Adeptus (ADPT) declined 22.3% to $46.50 after an NBC affiliate published an investigative report scrutinizing billing practices at freestanding emergency rooms in Colorado. INDEXES: The Dow rose 6.49, or 0.04%, to 17,489.50, the Nasdaq gained 1.40, or 0.03%, to 4,986.02, and the S&P 500 slipped 2.75, or 0.13%, to 2,050.44.
13:19 EDTMONMonsanto weighs another takeover offer for Syngenta, Bloomberg reports
Monsanto (MON) is weighing another takeover attempt for Syngenta (SYT) after China National Chemical Corporation made an offer for Syngenta, Bloomberg reports. Monsanto is having internal discussions over the benefits of a new offer, the report says, citing comments from COO Brett Begemann in front of reporters in St. Louis. Reference Link
12:54 EDTMONMonsanto targets over 1.3B acres of technology upgrades from platforms by 2025
During Monsanto company's Biennial Investor Event, the company will note that it operates from a global footprint of more than 400M acres currently using its technologies, with the company anticipating more than 1.3B acres of next-generation technology upgrades by 2025. Approximately 800M acres of upgrades are expected to come from its core growth drivers like Intacta RR2 PRO soybeans, Roundup Ready 2 Xtend soybeans and from its global corn portfolio. The company anticipates another 550M-900M acres of technology upgrades from its new growth platforms, including 300M-400M acres from the Climate FieldView digital agronomic platform and 250M-500M acres from the BioAg Alliance with Novozymes.
12:51 EDTMONMonsanto sees more than 20% CAGR in ongoing EPS from end of FY16 to FY19
Subscribe for More Information
12:48 EDTMONMonsanto confirms FY16 EPS view of $5.10-$5.60, consensus $5.33
Subscribe for More Information
11:34 EDTMONMonsanto to host two day biennial investor event
Subscribe for More Information
11:27 EDTMONMonsanto still sees earnings doubling by 2019, Bloomberg reports
Monsanto (MON) COO Brett Begemann told reporters ahead of the company's biennial investor event tomorrow that his company still expects its earnings to double between 2014 and 2019, according to Bloomberg. Begemann added that Monsanto management is internally discussing making another takeover approach to Syngenta (SYT), the news agency added. Begemann noted that acquisitions are not needed for Monsanto to double earnings by 2019. He expects 20% earnings growth in 2017, 2018 and 2019, Bloomberg reports.
11:24 EDTMONSyngenta jumps 3% after Monsanto says discussing another approach
Subscribe for More Information
11:23 EDTMONMonsanto COO says internally discussing another Syngenta approach
Subscribe for More Information
10:47 EDTBMYBristol-Myers strength attributed to sale chatter
The move higher in shares of Bristol-Myers (BMY) is being attributed by traders to chatter of a sale. The stock is up 2%, or $1.06, to $66.08 in morning trading. The unconfirmed talk has the company possibly approaching Gilead (GILD) about buyout interest. Bristol's market capitalization is just above $110B while Gilead's is just above $150B. Shares of Gilead are up 74c to $104.55.
08:39 EDTPXDPioneer Natural most likely large-cap E&P takeover candidate, says Canaccord
Canaccord believes Pioneer Natural (PXD) would be the most likely large cap takeover candidate in the E&P space, but said there is no way a major could make it an immediately accretive asset. The firm also thinks Callon Petroleum (CPE) would be the most likely small to mid-cap acquisition candidate given its high quality core Midland acreage and relatively cheap valuation.
November 16, 2015
17:10 EDTMONSoros took stake in Paypal, liquidated Herbalife stake
Soros Fund Management gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: Paypal (PYPL), CIT Group (CIT), Schlumberger (SLB), Kraft Heinz (KHC), and Amazon (AMZN). INCREASED STAKES: Allergan (AGN), Lions Gate (LGF), Energen (EGN), Southwest Airlines (LUV), and Qunar Cayman Islands (QUNR). DECREASED STAKES: LyondellBasell (LYB), YPF (YPF), Time Warner Cable (TWC), Dow Chemical (DOW), and Monsanto (MON). LIQUIDATED STAKES: Herbalife (HLF), Lennar (LEN), DR Horton (DHI), United Continental (UAL), and Nice Systems (NICE).
17:05 EDTBMYBristol-Myers announces FDA accepts for priority review sBLA for Opdivo
Bristol-Myers Squibb Company announced that the U.S. FDA has accepted for filing and priority review a supplemental Biologics License Application for Opdivo for the treatment of patients with advanced renal cell carcinoma who have received prior anti-angiogenic therapy. The FDA previously granted Opdivo Breakthrough Therapy Designation for this indication, underscoring the critical need for new treatment options for patients with advanced RCC who have received prior therapy. The projected FDA action date is March 16, 2016.
07:00 EDTBMYBristol-Myers announces data from Phase 3 ALLY-3+ trial for Daklinza
Bristol-Myers announced late-breaking data from the Phase 3 ALLY-3+ trial investigating a regimen of Daklinza in combination with sofosbuvir and ribavirin in genotype 3 hepatitis C patients with advanced fibrosis or cirrhosis, for treatment durations of 12 and 16 weeks. This patient population is one of the most difficult to treat, among whom sustained virologic response rates, or cure, have proved harder to achieve. The results show that 100% of patients in the advanced fibrosis cohort achieved SVR12 in both the 12- and 16-week arms of the study. SVR12 rates were 83% and 89% in patients with cirrhosis in the 12- and 16-week arms, respectively.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use